Quinone oxidoreductase (NQO1) gene polymorphism may not confer a susceptibility to mood disorders.
Psychiatry Res
; 153(1): 83-6, 2007 Sep 30.
Article
in En
| MEDLINE
| ID: mdl-17644186
ABSTRACT
Quinone oxidoreductase (NQO1) plays a key role in the cellular antioxidant defense by detoxifying quinine derivatives. Case-control association study of the possible relationship between the NQO1 gene polymorphism and mood disorders (patients with major depressive disorder, n=61; patients with bipolar I disorder, n=80; control, n=106) was carried out using PCR-based techniques. These preliminary results showed that the NQO1 gene polymorphism was not related to a susceptibility to mood disorders.
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Polymorphism, Genetic
/
Bipolar Disorder
/
NAD(P)H Dehydrogenase (Quinone)
/
Genetic Predisposition to Disease
/
Depressive Disorder, Major
Type of study:
Diagnostic_studies
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Asia
Language:
En
Journal:
Psychiatry Res
Year:
2007
Type:
Article
Affiliation country:
South Korea